Researchers at the Institute of Science Tokyo reported a strategy to block xenophagocytosis, an immune process that limits interspecies organ generation. By uncovering how embryonic macrophages eliminate living donor cells, the team developed approaches that improved donor cell survival and increased rat pancreas generation in mice. The findings address a key barrier for producing transplantable human organs in animals: host immune clearance of donor cells during early development. The reported improvements bring interspecies organ generation closer to practical feasibility. For translational organ-generation platforms, the work underscores that immune modulation—specifically controlling macrophage-mediated donor cell elimination—may be required alongside scaffold and developmental programming strategies. While still preclinical, the result provides a concrete mechanistic target—xenophagocytosis—to guide future protocols and reduce early-stage donor cell loss in interspecies models.